Masashi Sasa Selected Research

Masashi Sasa Research Topics

Disease

21	Seizures (Absence Seizure) 01/2019 - 09/2002
5	Tremor (Tremors) 01/2015 - 08/2002
4	Epilepsy (Aura) 01/2016 - 08/2002
3	Motor Disorders 11/2015 - 07/2008
2	Cognitive Dysfunction 01/2019 - 11/2015
2	Drug Resistant Epilepsy 01/2013 - 11/2011
2	Febrile Seizures (Febrile Seizure) 02/2011 - 04/2010
1	Mood Disorders (Mood Disorder) 11/2015
1	Parkinsonian Disorders (Parkinsonism) 11/2015
1	Dyskinesias (Dyskinesia) 11/2015
1	Type 2 Episodic Ataxia 01/2015
1	Temporal Lobe Epilepsy 01/2015
1	Type 1 Episodic Ataxia 01/2015
1	Hippocampal Sclerosis 08/2011
1	Generalized Epilepsy with Febrile Seizures Plus 02/2011
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 02/2011
1	Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic) 04/2010
1	Catalepsy 10/2008
1	Hypokinesia (Bradykinesia) 07/2008
1	Absence Epilepsy (Childhood Absence Epilepsy) 02/2007
1	Hypersensitivity (Allergy) 08/2003
1	Partial Epilepsies (Epilepsy, Partial) 08/2002
1	Mental Disorders (Mental Disorder) 02/2002
1	AIDS-Related Complex (ARC) 02/2002
1	Schizophrenia (Dementia Praecox) 02/2002

Drug/Important Bio-Agent (IBA)

6	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 07/2004
6	Levetiracetam (Keppra)FDA LinkGeneric 01/2013 - 08/2005
5	Pentylenetetrazole (Metrazol)IBA 01/2019 - 09/2010
4	aspartoacylaseIBA 04/2007 - 08/2002
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2013
2	Phenytoin (Dilantin)FDA LinkGeneric 02/2011 - 02/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 02/2011 - 02/2007
2	Ethosuximide (Zarontin)FDA LinkGeneric 02/2011 - 02/2007
2	Antipsychotic Agents (Antipsychotics)IBA 10/2008 - 07/2008
2	Haloperidol (Haldol)FDA LinkGeneric 10/2008 - 07/2008
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 10/2008 - 07/2008
2	N-acetylaspartate (N-acetyl aspartate)IBA 09/2003 - 08/2002
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	Serotonin ReceptorsIBA 11/2015
1	Levodopa (L Dopa)FDA LinkGeneric 11/2015
1	ICI D2788IBA 01/2015
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2015
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2015
1	Neuroprotective AgentsIBA 08/2011
1	Diazepam (Valium)FDA LinkGeneric 02/2011
1	SodiumIBA 02/2011
1	Sodium Channels (Sodium Channel)IBA 04/2010
1	Trihexyphenidyl (Artane)FDA LinkGeneric 10/2008
1	Fenclonine (p-Chlorophenylalanine)IBA 07/2008
1	Serotonin (5 Hydroxytryptamine)IBA 07/2008
1	WAY 100135IBA 07/2008
1	5-HT1A Serotonin ReceptorIBA 07/2008
1	Serotonin 5-HT1 Receptor AntagonistsIBA 07/2008
1	tandospironeIBA 07/2008
1	S 312IBA 07/2004
1	benzocycloheptapyridineIBA 07/2004
1	GTP-Binding Proteins (G-Protein)IBA 09/2003
1	Dopamine (Intropin)FDA LinkGeneric 08/2003
1	Methamphetamine (Desoxyn)FDA LinkGeneric 08/2003
1	Dihydrotachysterol (AT 10)IBA 09/2002
1	Glutamic Acid (Glutamate)FDA Link 09/2002
1	beta-Galactosidase (Lactaid)IBA 08/2002
1	Vigabatrin FDA Link 08/2002
1	4-Aminobutyrate Transaminase (4 Aminobutyrate Transaminase)IBA 08/2002
1	Butyric Acid (Butanoic Acid)IBA 08/2002
1	N-Methylaspartate (NMDA)IBA 02/2002
1	LigandsIBA 02/2002
1	Nootropic Agents (Nootropics)IBA 02/2002
1	sigma Receptors (sigma Receptor)IBA 02/2002

Therapy/Procedure

1	Induced Hyperthermia (Thermotherapy) 04/2010
1	Oral Administration 07/2004